AT368755B - Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate - Google Patents

Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate

Info

Publication number
AT368755B
AT368755B AT0278880A AT278880A AT368755B AT 368755 B AT368755 B AT 368755B AT 0278880 A AT0278880 A AT 0278880A AT 278880 A AT278880 A AT 278880A AT 368755 B AT368755 B AT 368755B
Authority
AT
Austria
Prior art keywords
ketohexopyranoside
derivatives
producing new
new alkyl
alkyl
Prior art date
Application number
AT0278880A
Other languages
English (en)
Other versions
ATA278880A (de
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of ATA278880A publication Critical patent/ATA278880A/de
Application granted granted Critical
Publication of AT368755B publication Critical patent/AT368755B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT0278880A 1979-05-23 1980-05-23 Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate AT368755B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6476979A JPS55154991A (en) 1979-05-23 1979-05-23 Beta-d-fructopyranoside derivative

Publications (2)

Publication Number Publication Date
ATA278880A ATA278880A (de) 1982-03-15
AT368755B true AT368755B (de) 1982-11-10

Family

ID=13267727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0278880A AT368755B (de) 1979-05-23 1980-05-23 Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate

Country Status (16)

Country Link
US (1) US4395405A (de)
JP (1) JPS55154991A (de)
AR (1) AR225310A1 (de)
AT (1) AT368755B (de)
AU (1) AU529742B2 (de)
CA (1) CA1141761A (de)
CH (1) CH647531A5 (de)
DE (1) DE3019221A1 (de)
ES (1) ES8104321A1 (de)
FR (1) FR2457300A1 (de)
GB (1) GB2052485B (de)
IT (1) IT1140976B (de)
NL (1) NL8002981A (de)
SE (1) SE8003815L (de)
SU (1) SU978732A3 (de)
ZA (1) ZA803076B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5946222A (ja) * 1982-09-10 1984-03-15 Ss Pharmaceut Co Ltd 抗癌剤
DE3444958A1 (de) * 1984-12-10 1986-06-12 Henkel KGaA, 4000 Düsseldorf Verwendung von alkylglykosiden als potenzierungsmittel in antiseptischen mitteln sowie desinfektions- und reinigungsmittel mit verstaerkter bakterizider wirkung
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
US5298494A (en) * 1989-01-09 1994-03-29 Greenwich Pharmaceuticals Incorporated Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
WO1992004359A2 (en) * 1990-09-12 1992-03-19 Greenwich Pharmaceuticals, Inc. Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2959893A1 (de) 2002-12-13 2015-12-30 DURECT Corporation Orales arzneimittelverabreichungssystem mit hochviskosen flüssigkeitsträgermaterialien
WO2005067960A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-DERIVED SYNTHETIC PEPTIDES, AND THEIR USE IN THERAPY TO INHIBIT TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS
CA2581287C (en) * 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
WO2007097903A2 (en) 2006-02-02 2007-08-30 Trimeris, Inc. Hiv fusion inhibitor peptides with improved biological properties
EP2117521B1 (de) 2006-11-03 2012-06-27 Durect Corporation Transdermale abgabesysteme mit bupivacain
JP2010523564A (ja) * 2007-04-03 2010-07-15 トリメリス，インコーポレーテッド 抗ウイルス性ペプチド治療薬の送達のための新規製剤
EP2201028A2 (de) * 2007-09-25 2010-06-30 Trimeris, Inc. Neues verfahren zur synthese therapeutischer antiviraler peptide
WO2009088414A2 (en) 2007-12-06 2009-07-16 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
KR102413459B1 (ko) 2016-07-06 2022-06-24 듀렉트 코퍼레이션 약물 조성물, 장벽 층 및 약물 층을 갖는 경구 투여 형태
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
EP4277702A1 (de) 2021-01-12 2023-11-22 Durect Corporation Systeme zur wirkstofffreisetzung mit verzögerter freisetzung und zugehörige verfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) * 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US2949449A (en) * 1959-01-14 1960-08-16 Hoffmann La Roche Synthesis of 3, 5-diaroyl-2-deoxy-d-ribofuranosyl ureas
US3243425A (en) * 1962-10-29 1966-03-29 Purdue Research Foundation Novel sulfur-containing compounds
US3721663A (en) * 1970-03-02 1973-03-20 Merck & Co Inc Novel method for preparing ascorbic acid compounds and novel intermediates for preparing same
CA1074308A (en) * 1977-04-22 1980-03-25 Walter A. Szarek L-sucrose and process for producing same

Also Published As

Publication number Publication date
SU978732A3 (ru) 1982-11-30
JPS55154991A (en) 1980-12-02
IT1140976B (it) 1986-10-10
DE3019221A1 (de) 1980-12-04
US4395405A (en) 1983-07-26
ES492194A0 (es) 1981-04-01
FR2457300B1 (de) 1983-06-24
GB2052485B (en) 1983-04-07
ZA803076B (en) 1981-06-24
CA1141761A (en) 1983-02-22
ES8104321A1 (es) 1981-04-01
GB2052485A (en) 1981-01-28
SE8003815L (sv) 1980-11-24
ATA278880A (de) 1982-03-15
AU5861580A (en) 1980-11-27
IT8022265A0 (it) 1980-05-22
FR2457300A1 (fr) 1980-12-19
AR225310A1 (es) 1982-03-15
NL8002981A (nl) 1980-11-25
AU529742B2 (en) 1983-06-16
CH647531A5 (fr) 1985-01-31

Similar Documents

Publication Publication Date Title
AT371817B (de) Verfahren zur herstellung neuer ergolinderivate
AT368507B (de) Verfahren zur herstellung neuer penicillinderivate
AT377257B (de) Verfahren zur herstellung neuer thiadiazolderivate
AT373599B (de) Verfahren zur herstellung neuer rifamycinderivate
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
AT373251B (de) Verfahren zur herstellung neuer d-6-n-propylergoline
ATA246780A (de) Verfahren zur herstellung neuer pyrazinobenzodiazepine
AT374806B (de) Verfahren zur herstellung neuer cephalosporinderivate
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
PT71116A (de) Verfahren zur herstellung neuer cyclobutandicarbonsaureimide
AT367060B (de) Verfahren zur herstellung neuer cephalosporinderivate
AT362389B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
AT376217B (de) Verfahren zur herstellung neuer 3-chlorchinolinderivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
AT370085B (de) Verfahren zur herstellung neuer aminobenzoesaeure- derivaten
DD134765A5 (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
AT362798B (de) Verfahren zur herstellung neuer nitrosoharnstoff-derivate
ATA330284A (de) Verfahren zur herstellung neuer thiadiazolderivate
AT373240B (de) Verfahren zur herstellung neuer pyridyloxyphenoxyalkancarbonsaeurederivate
ATA269880A (de) Verfahren zur herstellung neuer pyridinderivate
ATA583379A (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee